,datetime,sentence,positive,negative,neutral,global_sentiment,avg_sentiment
0,2015-03-24 22:20:00,"Veeva SystemsVEEV recently launched Veeva OpenKey - which provides customer data for all healthcare professionals (HCP), healthcare organizations (HCO), and affiliations across life sciences' major markets.",0.0771184116601944,0.004732310771942139,0.9181492328643799,neutral,0.07238610088825226
1,2015-03-24 22:20:00,"The company also announced the OpenKey Partner Program, which looks to forge collaborations with major life sciences companies.",0.8415048718452454,0.012493398040533066,0.14600177109241486,positive,0.8290114998817444
2,2015-03-24 22:20:00,"Due to restrictive vendor contracts, Life Sciences companies are unable to fully leverage the customer data they purchase.",0.021580900996923447,0.8547748923301697,0.12364421784877777,negative,-0.8331940174102783
3,2015-03-24 22:20:00,Preliminary results of the Veeva 2015 European Life Sciences Industry Survey showed that 83% of life sciences executives are unhappy with the quality of customer data they have access to.,0.02355320379137993,0.961217999458313,0.015228879638016224,negative,-0.937664806842804
4,2015-03-24 22:20:00,Veeva OpenKey is aimed at obliterating such complexities with the help of data access agreements and partnerships with other third-party providers.,0.7279806137084961,0.01275725569576025,0.25926220417022705,positive,0.7152233719825745
5,2015-03-24 22:20:00,We feel the launch of Veeva OpenKey will help the company gain better market traction by expanding its existing presence in the data business.,0.9505696296691895,0.015374493785202503,0.03405586630105972,positive,0.9351951479911804
6,2015-03-24 22:20:00,"Recently, Veeva was selected by GlaxoSmithKline GSK as the latter's multichannel Customer Relationship Management (CRM) partner.",0.6086967587471008,0.010020247660577297,0.3812830150127411,positive,0.5986765027046204
7,2015-03-24 22:20:00,This strategic partnership is expected to position Veeva as one of the leading providers of cloud-based CRM solutions for life sciences and pharmaceutical companies.,0.8986524343490601,0.01202516071498394,0.0893222987651825,positive,0.8866272568702698
8,2015-03-24 22:20:00,"In Dec 2014, Veeva opened two new European data centers in Germany and the U.K.",0.40556544065475464,0.008993547409772873,0.585440993309021,neutral,0.39657190442085266
9,2015-03-24 22:20:00,"The data centers are expected to support European and global customers' needs for all of the company's cloud-based solutions such as Veeva CRM, Veeva Network and Veeva Vault.",0.7705461978912354,0.010214343667030334,0.2192395180463791,positive,0.7603318691253662
10,2015-03-24 22:20:00,Veeva also announced the availability of the Veeva Network Provider Database in Europe.,0.5361219644546509,0.008809306658804417,0.4550687074661255,positive,0.5273126363754272
11,2015-03-24 22:20:00,"This is expected to provide life sciences companies with access to accurate HCP, HCO and affiliations data.",0.5297244191169739,0.009231374599039555,0.46104416251182556,positive,0.5204930305480957
12,2015-03-24 22:20:00,We feel such positive developments will bode well for the company and eventually result in better top-line growth.,0.94456946849823,0.0148422596976161,0.04058827832341194,positive,0.9297271966934204
13,2015-03-24 22:20:00,"Currently, Veeva has a Zacks Rank #2 (Buy).",0.49980178475379944,0.02152741327881813,0.4786708652973175,positive,0.4782743752002716
14,2015-03-24 22:20:00,Some other top-ranked stocks in the medical sector are LeMaitre Vascular LMAT and SurModics SRDX .,0.41656848788261414,0.01432054489850998,0.5691109895706177,neutral,0.40224793553352356
15,2015-03-24 22:20:00,Both the stocks carry a Zacks Rank #1 (Strong Buy).,0.8167514801025391,0.05983145534992218,0.12341706454753876,positive,0.7569200396537781
16,2015-03-24 22:20:00,Want the latest recommendations from Zacks Investment Research?,0.03539300337433815,0.011573811061680317,0.9530332088470459,neutral,0.023819193243980408
17,2015-03-24 22:20:00,"Today, you can download 7 Best Stocks for the Next 30 Days.",0.05069372057914734,0.007019792217761278,0.9422864317893982,neutral,0.04367392882704735
18,2015-03-24 22:20:00,"Click to get this free report

To read this article on Zacks.com click here.",0.020684564486145973,0.03315984085202217,0.9461556077003479,neutral,-0.012475276365876198
19,2015-03-24 22:20:00,"The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.",0.010204561054706573,0.01563790813088417,0.9741575717926025,neutral,-0.005433347076177597
